Back to Authors

Glass, David J.

https://orcid.org/0000-0001-6187-4164

A5054558716 | I186523950

Mayo Clinic

Regeneron (United States)

Citations 3

Alternative Pathway Complement Activation and Low Circulating Inhibitors Associate With Severity and Mortality in COVID-19 and Non-COVID Sepsis

A103. DYSREGULATED PATHWAYS IN SEPSIS AND LUNG INJURY: SEARCHING FOR TREATABLE TRAITS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A2830-A2830

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2830

Meeting Report: Aging Research and Drug Discovery

Aging | January 28, 2022 | Volume: 14 | Issue: 2 | Pages: 530-543

10.18632/aging.203859

G protein-coupled receptor 56 regulates mechanical overload-induced muscle hypertrophy

Proceedings of the National Academy of Sciences | October 22, 2014 | Volume: 111 | Issue: 44 | Pages: 15756-15761

10.1073/pnas.1417898111 | PMID 25336758

Significance The work reported in this paper describes a previously unknown signaling pathway in skeletal muscle acting through G protein-coupled receptor 56-Galpha12/13. This discovery elucidates a previously unknown mechanism of muscle anabolism and gives another target of investigation for therapies against the loss of muscle mass seen with aging and various wasting diseases.